Global microarray scanners market is expected to reach XX billion by 2027Global Microarray Scanners market is valued approximately at XXX billion in 2020 and is anticipated to grow with a healthy growth rate of about XX% over the forecast period 2021-2027. Microarray scanners refer to the devices that are used for the measurement of fluorescent areas in a DNA microarray to disclose information about the simultaneous activity of thousands of genes. Microarray scanners are widely being adopted in cellomics, functional biology, gene expression as well as drug discovery research. The global microarray scanners market is being driven by rise in demand for preventive healthcare and rapidly increasing geriatric population. Furthermore, technological advancements will provide new opportunities for the global microarray scanners industry. According to the United Nations (World Population Ageing 2019 Report), geriatric population (65 years or more) is expected to reach more than 1.5 billion by 2050 from nearly 727 million persons in 2020. Such increase in geriatric population is expected to increase the adoption of microarray scanners and is expected to drive the market growth during the forecast period. However, strict government regulations may impede market growth over the forecast period of 2021-2027.

The regional analysis of the global microarray scanners market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region across the world in terms of market share due to factors such as established life sciences and healthcare industries, awareness regarding infectious and chronic diseases, early adoption of advanced products, etc. Asia Pacific is anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due to factors such as healthcare sector expansion, research & development in drug development, etc. in the region.

Major market player included in this report are:
Thermo Fisher Scientific
Agilent Technologies
Illumina, Inc.
PerkinElmer, Inc.
F. Hoffmann-La Roche Ltd.
GE Healthcare
Molecular Devices, LLC
Innopsys, Inc.
Berthold Technologies GmbH & Co. KG
Arrayit

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Fluorescence Microarray Scanners
Charge-coupled Devices Microarray Scanners
Colorimetric Microarray Scanners
Others
By Application:
Gene Expression
Drug Discovery
Others
By End User:
Hospitals
Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027.

Target Audience of the Global Microarray Scanners Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors